Taiwan Rule To Buy Only Local H1N1 Vaccine Criticized By Experts
This article was originally published in PharmAsia News
Executive Summary
Taiwan's decision to buy an H1N1 vaccine from the only local vaccine maker without also importing the drug is facing criticism by some experts. The government's bid system for purchases drew only one bidder, Taiwan's Adimmune, one-fifth owned by the government. Adimmune has relatively little experience compared with many foreign makers, and has yet to begin human trails on its version. The new purchase order given the company by the government seeks another 5 million doses. (Click here for more